We evaluated the effects of several process variable on the pharmaceutical
an drug release properties of extrusion-spheronization pellets of blends of
Carbopol 934 and microcrystalline cellulose (MCC) containing a high propor
tion of Carbopol. The model drug was theophylline. Rheological monitoring d
uring mixing was by mixer torque rheometry. Carbopol: MCC blends wetted wit
h a CaCl2 solution showed different rheological behavior compared to blends
with a high proportion of MCC wetted with water only. In contrast to previ
ous suggestions, the optimal wetting point for extrusion did not coincide w
ith the point of peak torque, but occurred just beyond this point, at much
lower torque. The influence of process variables on blend properties was in
vestigated with a three-variable factorial design (Carbopol: MCC ratio, wet
ting liquid proportion, CaCl2: Carbopol ratio), and the influence of proces
s variable on pellet properties with a four-variable design (the variables
listed plus extrusion screen hole diameter). Blend torque values were stron
gly influenced by CaCl2 proportion, while mean pellet diameter was influenc
ed by Carbopol: MCC ratio. Mean pellet diameter also differed depending on
whether the pellets contained theophylline. The observed among-formulation
differences in theophylline release kinetics were largely explained by diff
erences in pellet size and theophylline hydration state. Compaction of pell
ets to form tablets markedly modified the drug release profile, making it b
iphasic.